Caribou Biosciences, Inc. (CRBU) Executive Compensation
Caribou Biosciences, Inc. (CRBU) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CRBU
CIK: 1619856
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerKelsey Yuan
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-06 | 2026-10-02 | 8-K | 0001193125-26-415559 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001619856-26-000055 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001619856-26-000053 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002279 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-17 | 8-K | 0001619856-26-000047 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-11 | 8-K | 0001619856-26-000043 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-05 | — | DEFA14A | 0001619856-26-000039 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001619856-26-000036 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001619856-26-000035 | View SEC Doc Filr Page |
| DEFR14A | 2026-05-01 | — | DEFR14A | 0001619856-26-000028 | View SEC Doc Filr Page |
| ARS | 2026-04-24 | 2025-12-31 | ARS | 0001619856-26-000024 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-24 | — | DEFA14A | 0001619856-26-000023 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-24 | 2025-12-31 | DEF 14A | 0001619856-26-000022 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-10 | 2025-12-31 | PRE 14A | 0001619856-26-000015 | View SEC Doc Filr Page |
| 8-K | 2026-03-31 | 2026-03-31 | 8-K | 0001619856-26-000012 | View SEC Doc Filr Page |
| S-8 | 2026-03-05 | — | S-8 | 0001193125-26-094237 | View SEC Doc Filr Page |
| 10-K | 2026-03-05 | 2025-12-31 | 10-K | 0001619856-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-03-05 | 2026-03-05 | 8-K | 0001619856-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-02-27 | 2026-02-25 | FORM 4 | 0001754067-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-02-25 | — | 144 Filing | 0001891113-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-02-25 | — | 144 Filing | 0001231321-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-02-25 | — | 144 Filing | 0001950047-26-001807 | View SEC Doc Filr Page |
| 4 | 2026-02-24 | 2026-02-20 | FORM 4 | 0001754067-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-02-24 | 2026-02-20 | FORM 4 | 0001231321-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-02-24 | 2026-02-20 | FORM 4 | 0001891113-26-000002 | View SEC Doc Filr Page |